{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:44:03Z","timestamp":1792111443088,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"DOI":"10.1007\/s12185-026-04298-9","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:46:58Z","timestamp":1792108018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The prognostic impact of CDH1 and MEG3 methylation status in multiple myeloma"],"prefix":"10.1007","author":[{"given":"Satoru","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2564-0568","authenticated-orcid":false,"given":"Takuto","family":"Tachita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Mayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazufumi","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotake","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"issue":"5","key":"4298_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/S12185-019-02636-8\/METRICS","volume":"109","author":"S Iida","year":"2019","unstructured":"Iida S, Ishida T, Murakami H, et al. JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-1. Multiple myeloma (MM). Int J Hematol. 2019;109(5):509\u201338. https:\/\/doi.org\/10.1007\/S12185-019-02636-8\/METRICS.","journal-title":"Int J Hematol"},{"key":"4298_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3257","author":"GJ Morgan","year":"2012","unstructured":"Morgan GJ, Walker BA, Davies FE. The genetic architecture of multiple myeloma. 2012. https:\/\/doi.org\/10.1038\/nrc3257.","journal-title":"The genetic architecture of multiple myeloma"},{"issue":"26","key":"4298_CR3","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","volume":"33","author":"A Palumbo","year":"2015","unstructured":"Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol. 2015;33(26):2863\u20139. https:\/\/doi.org\/10.1200\/JCO.2015.61.2267.","journal-title":"J Clin Oncol"},{"key":"4298_CR4","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1200\/JCO.21.02614","volume":"364","author":"M D\u2019agostino","year":"2022","unstructured":"D\u2019agostino M, Cairns DA, Lahuerta JJ, et al. Second revision of the International Staging System (R2-ISS) for overall survival in multiple myeloma: a European Myeloma Network (EMN) report within the HARMONY Project. J Clin Oncol. 2022;364:3406\u201318. https:\/\/doi.org\/10.1200\/JCO.21.02614.","journal-title":"J Clin Oncol"},{"issue":"6","key":"4298_CR5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1182\/blood-2018-03-840132","volume":"132","author":"BA Walker","year":"2018","unstructured":"Walker BA, Mavrommatis K, Wardell CP, et al. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. Blood. 2018;132(6):587\u201397. https:\/\/doi.org\/10.1182\/blood-2018-03-840132.","journal-title":"Blood"},{"issue":"5","key":"4298_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/bjh.16720","volume":"191","author":"T Kanamori","year":"2020","unstructured":"Kanamori T, Sanada M, Ri M, et al. Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort. Br J Haematol. 2020;191(5):755\u201363. https:\/\/doi.org\/10.1111\/bjh.16720.","journal-title":"Br J Haematol"},{"issue":"12","key":"4298_CR7","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1038\/s41375-018-0037-9","volume":"32","author":"N Bolli","year":"2018","unstructured":"Bolli N, Biancon G, Moarii M, et al. Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups. Leuk. 2018;32(12):2604\u201316. https:\/\/doi.org\/10.1038\/s41375-018-0037-9.","journal-title":"Leuk."},{"issue":"5","key":"4298_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1006\/scbi.1999.0138","volume":"9","author":"JG Herman","year":"1999","unstructured":"Herman JG. Hypermethylation of tumor suppressor genes in cancer. Semin Cancer Biol. 1999;9(5):359\u201367. https:\/\/doi.org\/10.1006\/scbi.1999.0138.","journal-title":"Semin Cancer Biol"},{"issue":"15","key":"4298_CR9","doi-asserted-by":"publisher","first-page":"8681","DOI":"10.1073\/PNAS.96.15.8681\/ASSET\/CAE2BE2A-DDC9-440E-A944-75432867C4DF\/ASSETS\/GRAPHIC\/PQ1692145005.JPEG","volume":"96","author":"M Toyota","year":"1999","unstructured":"Toyota M, Ahuja N, Ohe-Toyota M, et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999;96(15):8681\u20136. https:\/\/doi.org\/10.1073\/PNAS.96.15.8681\/ASSET\/CAE2BE2A-DDC9-440E-A944-75432867C4DF\/ASSETS\/GRAPHIC\/PQ1692145005.JPEG.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4298_CR10","unstructured":"Melki JR, Vincent PC, Clark SJ, \u201cConcurrent DNA hypermethylation of multiple genes in acute myeloid leukemia,\u201d Cancer Res., 59, 15, 1999, 3730\u20133740, Accessed: 2025. [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/10446989\/"},{"issue":"6","key":"4298_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","volume":"36","author":"PA Jones","year":"2002","unstructured":"Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;36(6):415\u201328. https:\/\/doi.org\/10.1038\/nrg816.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"4298_CR12","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1093\/hmg\/3.suppl_1.1487","volume":"3","author":"PW Laird","year":"1994","unstructured":"Laird PW, Jaenisch R. DNA methylation and cancer. Hum Mol Genet. 1994;3(1):1487\u201395. https:\/\/doi.org\/10.1093\/hmg\/3.suppl_1.1487.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4298_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/S12185-009-0459-2\/FIGURES\/6","volume":"91","author":"E Braggio","year":"2010","unstructured":"Braggio E, Maiolino A, Gouveia ME, et al. Methylation status of nine tumor suppressor genes in multiple myeloma. Int J Hematol. 2010;91(1):87\u201396. https:\/\/doi.org\/10.1007\/S12185-009-0459-2\/FIGURES\/6.","journal-title":"Int J Hematol"},{"issue":"5","key":"4298_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/cjp2.326","volume":"9","author":"Y Hara","year":"2023","unstructured":"Hara Y, Mizukami H, Yamazaki K, et al. Dual epigenetic changes in diabetes mellitus-associated pancreatic ductal adenocarcinoma correlate with downregulation of E-cadherin and worsened prognosis. J Pathol Clin Res. 2023;9(5):354\u201366. https:\/\/doi.org\/10.1002\/cjp2.326.","journal-title":"J Pathol Clin Res"},{"issue":"2","key":"4298_CR15","doi-asserted-by":"publisher","first-page":"100953","DOI":"10.1016\/J.MODPAT.2025.100953","volume":"39","author":"K Yamazaki","year":"2026","unstructured":"Yamazaki K, Mizukami H, Yamada T, et al. MEG3 promoter methylation and F11 receptor (F11R) overexpression define a high-risk subtype of diabetic pancreatic cancer. Mod Pathol. 2026;39(2):100953. https:\/\/doi.org\/10.1016\/J.MODPAT.2025.100953.","journal-title":"Mod Pathol"},{"issue":"10","key":"4298_CR16","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","volume":"68","author":"TT Onder","year":"2008","unstructured":"Onder TT, Gupta PB, Mani SA, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008;68(10):3645\u201354. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-2938.","journal-title":"Cancer Res"},{"key":"4298_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.12688\/f1000research.109551.1","volume":"11","author":"M Hirao","year":"2022","unstructured":"Hirao M, Yamazaki K, Watanabe K, et al. Negative E-cadherin expression on bone marrow myeloma cell membranes is associated with extramedullary disease. F1000Res. 2022;11:245. https:\/\/doi.org\/10.12688\/f1000research.109551.1.","journal-title":"F1000Res"},{"issue":"12","key":"4298_CR18","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1002\/cncr.20295","volume":"100","author":"S Seidl","year":"2004","unstructured":"Seidl S, Ackermann J, Kaufmann H, et al. DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies. Cancer. 2004;100(12):2598\u2013606. https:\/\/doi.org\/10.1002\/cncr.20295.","journal-title":"Cancer"},{"issue":"6","key":"4298_CR19","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/sj.leu.2404205","volume":"20","author":"C-S Chim","year":"2006","unstructured":"Chim C-S, Liang R, Leung M-H, et al. Aberrant gene promoter methylation marking disease progression in multiple myeloma. Leukemia. 2006;20(6):1190\u20132. https:\/\/doi.org\/10.1038\/sj.leu.2404205.","journal-title":"Leukemia"},{"issue":"3","key":"4298_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2443.2000.00320.x","volume":"5","author":"N Miyoshi","year":"2000","unstructured":"Miyoshi N, Wagatsuma H, Wakana S, et al. Identification of an imprinted gene, Meg3\/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells. 2000;5(3):211\u201320. https:\/\/doi.org\/10.1046\/j.1365-2443.2000.00320.x.","journal-title":"Genes Cells"},{"key":"4298_CR21","doi-asserted-by":"publisher","DOI":"10.1530\/JME-12-0008","author":"Y Zhou","year":"2012","unstructured":"Zhou Y, Zhang X, Klibanski A. MEG3 noncoding RNA: A tumor suppressor. J mol endocrin. 2012. https:\/\/doi.org\/10.1530\/JME-12-0008.","journal-title":"J mol endocrin"},{"issue":"6","key":"4298_CR22","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885\/655953\/P\/MATERNALLY-EXPRESSED-GENE-3-AN-IMPRINTED-NONCODING","volume":"70","author":"X Zhang","year":"2010","unstructured":"Zhang X, Gejman R, Mahta A, et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res. 2010;70(6):2350\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3885\/655953\/P\/MATERNALLY-EXPRESSED-GENE-3-AN-IMPRINTED-NONCODING.","journal-title":"Cancer Res"},{"issue":"1","key":"4298_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/J.BBRC.2016.05.031","volume":"478","author":"L Sun","year":"2016","unstructured":"Sun L, Li Y, Yang B. Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53\u2019s transcriptional activity. Biochem Biophys Res Commun. 2016;478(1):323\u20139. https:\/\/doi.org\/10.1016\/J.BBRC.2016.05.031.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"4298_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1039\/c2mb25386k","volume":"9","author":"L Ying","year":"2013","unstructured":"Ying L, Huang Y, Chen H, et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst. 2013;9(3):407\u201311. https:\/\/doi.org\/10.1039\/c2mb25386k.","journal-title":"Mol Biosyst"},{"issue":"2","key":"4298_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/MC.22270","volume":"55","author":"H Zhuo","year":"2016","unstructured":"Zhuo H, Tang J, Lin Z, et al. The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma. Mol Carcinog. 2016;55(2):209\u201319. https:\/\/doi.org\/10.1002\/MC.22270.","journal-title":"Mol Carcinog"},{"issue":"2","key":"4298_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.leukres.2009.06.019","volume":"34","author":"L Benetatos","year":"2010","unstructured":"Benetatos L, Hatzimichael E, Dasoula A, et al. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res. 2010;34(2):148\u201353. https:\/\/doi.org\/10.1016\/j.leukres.2009.06.019.","journal-title":"Leuk Res"},{"issue":"3","key":"4298_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3816\/CLM.2008.n.021","volume":"8","author":"L Benetatos","year":"2008","unstructured":"Benetatos L, Dasoula A, Hatzimichael E, et al. Promoter hypermethylation of the MEG3 (DLK1\/MEG3) imprinted gene in multiple myeloma. Clin Lymphoma Myeloma. 2008;8(3):171\u20135. https:\/\/doi.org\/10.3816\/CLM.2008.n.021.","journal-title":"Clin Lymphoma Myeloma"},{"issue":"1","key":"4298_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3892\/etm.2020.8723","volume":"20","author":"W Yu","year":"2020","unstructured":"Yu W, Shi Q, Wu C, et al. Promoter hypermethylation influences the suppressive role of long non-coding RNA MEG3 in the development of multiple myeloma. Exp Ther Med. 2020;20(1):637\u201345. https:\/\/doi.org\/10.3892\/etm.2020.8723.","journal-title":"Exp Ther Med"},{"key":"4298_CR29","doi-asserted-by":"publisher","first-page":"106967","DOI":"10.1016\/J.LEUKRES.2022.106967","volume":"123","author":"X Zang","year":"2022","unstructured":"Zang X, Wang J, Xia Y, et al. LncRNA MEG3 promotes the sensitivity of bortezomib by inhibiting autophagy in multiple myeloma. Leuk Res. 2022;123:106967. https:\/\/doi.org\/10.1016\/J.LEUKRES.2022.106967.","journal-title":"Leuk Res"},{"issue":"2","key":"4298_CR30","doi-asserted-by":"publisher","first-page":"e4580","DOI":"10.1371\/journal.pone.0004580","volume":"4","author":"Y Kam","year":"2009","unstructured":"Kam Y, Quaranta V. Cadherin-bound \u03b2-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between \u03b2-catenin pools. PLoS ONE. 2009;4(2):e4580. https:\/\/doi.org\/10.1371\/journal.pone.0004580.","journal-title":"PLoS ONE"},{"key":"4298_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138236","author":"A Petri","year":"2015","unstructured":"Petri A, Dybk\u00e6r K, B\u00f8gsted M, et al. Long noncoding RNA expression during human B-cell development. PLoS ONE. 2015. https:\/\/doi.org\/10.1371\/journal.pone.0138236.","journal-title":"PLoS ONE"},{"key":"4298_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cells11193181","author":"S Dadafarin","year":"2022","unstructured":"Dadafarin S, Rodr\u00edguez TC, Carnazza MA, et al. MEG3 expression indicates lymph node metastasis and presence of cancer-associated fibroblasts in papillary thyroid cancer. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11193181.","journal-title":"Cells"},{"issue":"3","key":"4298_CR33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12022-020-09626-1","volume":"31","author":"D Narayanan","year":"2020","unstructured":"Narayanan D, Mandal R, Hardin H, et al. Long non-coding RNAs in pulmonary neuroendocrine neoplasms. Endocr Pathol. 2020;31(3):254\u201363. https:\/\/doi.org\/10.1007\/s12022-020-09626-1.","journal-title":"Endocr Pathol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04298-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04298-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04298-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:46:59Z","timestamp":1792108019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04298-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":33,"alternative-id":["4298"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04298-9","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"6 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest associated with this work.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}